1. Achaogen Inc. (2019) Achaogen plans for near-term sale using structured process through chapter 11 of the U.S. bankruptcy code. Achaogen Inc
2. AMNOG-Monitor (2022) All resolutions on early benefit assessments §35a SGB V. https://www.amnog-monitor.com/procedures/resolutions/
3. Anderson M, Panteli D, Van Kessel R, Ljungqvist G, Colombo F, Mossialos E (2023) Challenges and opportunities for incentivising antibiotic research and development in Europe. http://creativecommons.org/licenses/by/4.0/
4. Andrew H (2022) Top 200 medicines report 2022: over the top. Pharma Live. https://www.pharmalive.com/over-the-top/
5. APEC Health Working Group (2024) Gap analysis of economic incentives for antimicrobials in APEC economies addressing barriers to market entry and new drug development. APEC Health Working Group